Search research articles
Contact Us
Filters
Showing results (31-40 of 68) with videos related to
Page
of 7
Sort By:
Blood Reviews
|
September 8, 2020
The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation
Mariam T Nawas, Johannes Schetelig, Frederik Damm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 18, 2011
Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes
Felicitas Thol, Inna Friesen, Frederik Damm, et al.
Blood Advances
|
May 5, 2021
Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myeloma
Stephan R Bohl, Laura K Schmalbrock, Imke Bauhuf, et al.
British Journal of Haematology
|
April 24, 2024
Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study)
Florence Nguyen-Khac, Marine Baron, Romain Guièze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2011
Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia
Frederik Damm, Tina Oberacker, Felicitas Thol, et al.
Blood
|
March 5, 2011
Integrative prognostic risk score in acute myeloid leukemia with normal karyotype
Frederik Damm, Michael Heuser, Michael Morgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2009
Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia
Frederik Damm, Michael Heuser, Michael Morgan, et al.
Blood
|
December 17, 2013
Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications
Felicitas Thol, Robin Bollin, Marten Gehlhaar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2010
Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor
Katharina Wagner, Frederik Damm, Gudrun Göhring, et al.
Annals of Hematology
|
April 11, 2012
Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes
Felicitas Thol, Haiyang Yun, Ann-Kathrin Sonntag, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 68) with videos related to
Sort By:
Page
of 7
Blood Reviews
|
September 8, 2020
The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation
Mariam T Nawas, Johannes Schetelig, Frederik Damm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 18, 2011
Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes
Felicitas Thol, Inna Friesen, Frederik Damm, et al.
Blood Advances
|
May 5, 2021
Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myeloma
Stephan R Bohl, Laura K Schmalbrock, Imke Bauhuf, et al.
British Journal of Haematology
|
April 24, 2024
Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study)
Florence Nguyen-Khac, Marine Baron, Romain Guièze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2011
Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia
Frederik Damm, Tina Oberacker, Felicitas Thol, et al.
Blood
|
March 5, 2011
Integrative prognostic risk score in acute myeloid leukemia with normal karyotype
Frederik Damm, Michael Heuser, Michael Morgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2009
Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia
Frederik Damm, Michael Heuser, Michael Morgan, et al.
Blood
|
December 17, 2013
Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications
Felicitas Thol, Robin Bollin, Marten Gehlhaar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2010
Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor
Katharina Wagner, Frederik Damm, Gudrun Göhring, et al.
Annals of Hematology
|
April 11, 2012
Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes
Felicitas Thol, Haiyang Yun, Ann-Kathrin Sonntag, et al.
Page
of 7